The arrangement of subunits in cholera toxin

Biochemistry
D M Gill

Abstract

Cholera toxin consists of five similar B subunits of apparent molecular weight about 10 600 and one A subunit (29 000) consisting of two peptides (A1 23 000-24 000 and A2 about 5500) linked by a single disulfide bond. Each B subunit also contains one internal disulfide bond which is readily reduced but is protected from carboxymethylation unless the reduced subunits are heated in urea. Tyrosine residues in A1 and in B subunits are readily iodinated, but the intact B assembly does not react with iodine. Upon reaction with the cross-linking reagent dimethyl suberimidate, B subunits may be covalently connected to each other, to A1 and to A2. A1 and A2 may also be cross-linked. The B subunits are probably arranged in a ring with A on the axis. A2 is required for the re-assembly of toxin from its subunits and may serve to hold A1 on the B ring. The maximum activity of cholera toxin in vitro is obtained only when the active peptide, A1, is separated from the rest of the molecule. Such separation, and the insertion of A1 into the cytosol, must follow the binding of the complete toxin, through component B, to the exterior of intact cells. This binding increases the effective concentration of the toxin in the vicinity of the plasma memb...Continue Reading

References

Jun 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·D M Gill
Jan 1, 1975·Journal of General Microbiology·J Holmgren, I Lonnroth
Sep 1, 1975·European Journal of Biochemistry·J Sattler, H Wiegandt
Jun 1, 1973·Journal of General Microbiology·I Lönnroth, J Holmgren
Aug 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M Field
Oct 1, 1974·European Journal of Biochemistry·J StaerkW Ziegler
Nov 27, 1974·Biochemical and Biophysical Research Communications·J W JacobsG W Sharp
Dec 1, 1972·The Journal of Infectious Diseases·J W PetersonR A Finkelstein
Jul 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·G E Davies, G R Stark
May 1, 1970·The Journal of Infectious Diseases·R A Finkelstein, J J LoSpalluto

❮ Previous
Next ❯

Citations

Aug 1, 1991·Journal of Electron Microscopy Technique·G Mosser, A Brisson
Jan 1, 1978·Journal of Supramolecular Structure·M Vaughan, J Moss
Jan 1, 1979·Journal of Supramolecular Structure·D E MarkelA Kurosky
Jan 1, 1979·Journal of Supramolecular Structure·D M Gill
Jan 1, 1979·Journal of Supramolecular Structure·B J WisnieskiJ S Bramhall
Jan 1, 1982·The Journal of Membrane Biology·P H Fishman
Jun 24, 1977·Biochimica Et Biophysica Acta·L G RodaG D'Agnolo
Jan 10, 1977·Biochemical and Biophysical Research Communications·C Y LaiM Wang
May 2, 1991·European Journal of Pharmacology·M Nozaki, N Sperelakis
Jan 1, 1984·The International Journal of Biochemistry·V P NoskovaA N Noskov
Sep 11, 1995·Journal of Immunological Methods·E HarokopakisM Tomasi
Jan 1, 1985·Toxicon : Official Journal of the International Society on Toxinology·C E OlsonJ W Burnett
Jan 1, 1994·Molecular Aspects of Medicine·G MenestrinaC Montecucco
Jan 1, 1985·Pharmacology & Therapeutics·D C RobertsonF Dorner
Apr 29, 1982·Biochimica Et Biophysica Acta·J Hagmann, P H Fishman
Dec 14, 1989·Biochimica Et Biophysica Acta·D Longbottom, S van Heyningen
May 16, 1990·Biochimica Et Biophysica Acta·M NodaM Vaughan
Aug 30, 1991·Gene·D K PandaJ Das
Sep 18, 2002·Archives of Medical Research·Edda SciuttoCarlos Larralde
Apr 16, 1999·Oral Microbiology and Immunology·G Hajishengallis, S M Michalek
Oct 29, 2008·Nature Reviews. Microbiology·Renée M TsolisAndreas J Bäumler
Feb 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J J MekalanosW R Romig
Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D M Gill, R Meren
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J J MekalanosS Falkow
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·G D Pearson, J J Mekalanos
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·T R HirstJ Holmgren
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D S LudwigR D Kornberg
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D S LudwigG K Schoolnik
Jun 1, 1979·The Journal of Cell Biology·N H Chua, G W Schmidt
Aug 25, 1982·Nucleic Acids Research·M L GennaroD A Broadbent
Jun 25, 1983·Nucleic Acids Research·M L Gennaro, P J Greenaway
May 11, 2011·Cold Spring Harbor Perspectives in Biology·Clifford A Lingwood

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of General Microbiology
I Lönnroth, J Holmgren
Proceedings of the National Academy of Sciences of the United States of America
E K SpicerD E Schafer
© 2021 Meta ULC. All rights reserved